• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
U.S. Neurotherapeutics Markets Product Image

U.S. Neurotherapeutics Markets

  • Published: November 1997
  • Region: United States
  • Frost & Sullivan

Landmark discoveries in the neurosciences are revolutionizing our understanding of the human brain and its chemical structure. This report from Frost & Sullivan covers new drugs designed to treat such diverse brain disorders as multiple sclerosis, ALS, Alzheimer s dementia, and stroke, as well as treatments for more mature markets. Competitive strategies, such as rereleasing new formulations of existing products, are discussed at length. And profiles for companies like Glaxo-Wellcome, Warner-Lambert, and Parke-Davis are included.

- Executive Summary

- The Richest Pipeline in the Industry

- Summary of Major Findings

- Conclusions

- Industry Challenges and Research Methodology

- Challenges Facing the Pharmaceutical Industry

- Time Frame Analysis of Industry Challenges

Note: Product cover images may vary from those shown


Our Clients

Our clients' logos